Technical Expertise

Our technical expertise and know-how in the design, modification and synthesis of peptide drugs enable us to guarantee high quality for our products and services.

Synthesis Performance

During the drug synthesis phase, the average success rate of our novel molecule synthesis exceeds 99.95%.

Quality Management

The company’s quality management system runs through the entire product lifecycle. We undergo regular audits by customers and regulatory authorities to fully verify the quality control of equipment, processes and products.

Derived Bio production facility

About Derived Bio

It possesses advanced and efficient capabilities in process R&D and large-scale manufacturing of peptide drugs.

The company’s core business covers the independent R&D, production and sales of peptide APIs and formulations with large market capacity and strong competitiveness both domestically and internationally.

Leveraging its technical strengths in peptide drug R&D and large-scale production, the company provides pharmaceutical research services for innovative peptide drugs and custom manufacturing services for peptide products to pharmaceutical enterprises at home and abroad.

Derived Bio production process video

Scaled Production Capacity

The company is capable of multi-kilogram scale manufacturing of side-chain chemically modified peptides and long-chain modified peptides. Our production capacity for peptide APIs has reached multi-ton scale.